Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-03-05

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $146.03 per share (Direct)
  Date: 2026-03-05 | Code: M | equity_swap_involved: false | shares_owned_after: 9,630.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 279 shares of Common Stock at $479.8871 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: false | shares_owned_after: 9,351.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 481 shares of Common Stock at $480.5581 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: false | shares_owned_after: 8,870.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 510 shares of Common Stock at $482.0479 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: false | shares_owned_after: 8,360.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,293 shares of Common Stock at $482.925 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: false | shares_owned_after: 7,067.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,728 shares of Common Stock at $484.0481 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: false | shares_owned_after: 5,339.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 2,625 shares of Common Stock at $484.9984 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: false | shares_owned_after: 2,714.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 798 shares of Common Stock at $486.2033 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: false | shares_owned_after: 1,916.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 1,199 shares of Common Stock at $487.0206 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: false | shares_owned_after: 717.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 587 shares of Common Stock at $487.9813 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: false | shares_owned_after: 130.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 324,518.00 | Footnotes: F11
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 258,117.00 | Footnotes: F12
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F13
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 10,962.00 | Footnotes: F14
• Sold 9,500 shares of Stock Options at $146.03 per share (Derivative)
  Date: 2026-03-05 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 202,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.
• F2: This transaction was executed in multiple trades at prices ranging from $479.14 to $480.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $480.28 to $481.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $481.52 to $482.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $482.52 to $483.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $483.53 to $484.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $484.61 to $485.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $485.61 to $486.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $486.62 to $487.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F10: This transaction was executed in multiple trades at prices ranging from $487.67 to $488.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F12: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F13: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F14: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.